OWC Pharmaceutical Research Corp
OWC Pharmaceutical Research Corp., through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products. It develops cannabis-based medical products for the treatment of various conditions, including multiple myeloma, psoriasis, post-traumatic stress disorder, chronic pain, and fibromyalgia. The company is also involved in developing cannabis… Read more
OWC Pharmaceutical Research Corp (OWCP) - Total Liabilities
Latest total liabilities as of September 2019: $5.78 Million USD
Based on the latest financial reports, OWC Pharmaceutical Research Corp (OWCP) has total liabilities worth $5.78 Million USD as of September 2019.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
OWC Pharmaceutical Research Corp - Total Liabilities Trend (2008–2018)
This chart illustrates how OWC Pharmaceutical Research Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
OWC Pharmaceutical Research Corp Competitors by Total Liabilities
The table below lists competitors of OWC Pharmaceutical Research Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
PCI-PAL PLC
LSE:PCIP
|
UK | GBX17.02 Million |
|
Perk International Inc
PINK:PRKI
|
USA | $318.06K |
|
Bio Preventive Medicine Corp.
TWO:6810
|
Taiwan | NT$115.46 Million |
|
CHINA COMM SRVCS-H
MU:CMW
|
Germany | €78.12 Billion |
Liability Composition Analysis (2008–2018)
This chart breaks down OWC Pharmaceutical Research Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.12 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.44 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 3.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how OWC Pharmaceutical Research Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for OWC Pharmaceutical Research Corp (2008–2018)
The table below shows the annual total liabilities of OWC Pharmaceutical Research Corp from 2008 to 2018.
| Year | Total Liabilities | Change |
|---|---|---|
| 2018-12-31 | $12.99 Million | +4703.59% |
| 2017-12-31 | $270.49K | -31.66% |
| 2016-12-31 | $395.78K | +267.74% |
| 2015-12-31 | $107.63K | +78.47% |
| 2014-12-31 | $60.30K | -52.95% |
| 2013-12-31 | $128.18K | +45.06% |
| 2012-12-31 | $88.36K | +107.52% |
| 2011-12-31 | $42.58K | +146.13% |
| 2008-12-31 | $17.30K | -- |